Controlling nanocage assembly, towards developing a one-health "plug & play" platform for targeted therapy

Yujie Sheng1, Mark J Sutton1,2, Kourosh H Ebrahimi1

  • 1Institute of Pharmaceutical Science, King's College London, London, UK. Kourosh.ebrahimi@kcl.ac.uk.

Chemical Communications (Cambridge, England)
|August 18, 2025
PubMed
Summary

Researchers engineered ferritin protein nanocages for a versatile "plug and play" platform. This advance enables sustainable manufacturing of nanomedicines targeting viruses, cancer, and bacteria.